Brief: Repare Therapeutics Inc. Q2 EPS USD -0.28
09/08/2023 22:27
Aug 9 (Reuters) - Repare Therapeutics Inc. Q2 income from operations USD -12.258 million. * Q2 pretax profit USD -8.836 million * Q2 EPS USD -0.28 * Q2 net income USD -11.946 million * Q2 operating expenses USD 42.507 million
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln